scanX
Zydus Life Science
add_icon

Zydus Life Science

1,124.50
+20.70
(1.88%)
Market Cap
1,13,151.00 Cr
PE Ratio
24.54
Volume
11,52,463.00
Day High - Low
1,125.00 - 1,092.60
52W High-Low
1,205.00 - 835.50
ann
There are new updates from the company15 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,13,151.00 Cr
EPS
50.09
PE Ratio
24.54
PB Ratio
4.16
Book Value
271.78
EBITDA
8,984.60
Dividend Yield
0.09 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
16.99
Debt to Equity
0.31
Analyst Rating and Forecast
- By Refinitiv from30 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+53.33 %
+53.33 %
Hold
Hold+23.33 %
+23.33 %
Sell
Sell+23.33 %
+23.33 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Zydus Life Sciences promoter group share transmission1 day ago
Prashant Babubhai Patel, a member of the promoter group of Zydus Life Sciences, has acquired 32,577 equity shares via transmission from the estate of Late Jasodaben Babubhai Patel. The disclosure was made under SEBI PIT Regulations on August 24, 2026.
neutral
Zydus Lifesciences receives ESGRAIL rating of 604 days ago
Zydus Lifesciences disclosed an independent ESG rating of 60 from SEBI-registered provider ESGRAIL. The assessment, based on public data, was assigned on August 21, 2026.
negative
HC bars Zydus Life from launching Dabrafenib drug7 days ago
A high court has barred Zydus Life Sciences from launching a drug containing Dabrafenib, a compound covered under a Novartis patent, restraining the company from commercialising the product.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,922.00
#1 4,61,152.20
37.96
#1 61,673.90
12.69
#1 11,565
26.53
49.61
Divis Laboratories
8,744.50
2,32,139.00
78.78
11,067.00
13.95
2,568
65.50
73.16
Torrent Pharmaceuticals
4,932.00
1,87,597.40
86.80
13,886.20
20.34
2,138
3.28
51.36
Cipla
1,422.00
1,14,875.60
34.18
29,044.60
2.24
3,870
-39.18
42.83
Zydus Life Science
1,124.50
#5 1,13,151.00
#2 24.54
#6 27,657.90
#4 17.64
#3 5,026
#8 -34.90
49.80
Laurus Labs
1,866.20
1,00,748.00
92.42
6,867.80
22.01
890
#1 123.93
68.10
Dr Reddys Laboratories
1,193.50
99,617.80
31.23
35,058.60
3.90
4,158
-69.10
49.57
Lupin
2,175.50
99,470.90
#1 17.92
29,038.90
#1 26.75
5,356
16.00
26.80
Mankind Pharma
2,365.00
97,673.50
47.28
14,636.40
14.85
1,938
29.13
37.36
Aurobindo Pharma
1,617.80
93,084.60
24.86
34,145.20
5.56
3,503
25.21
53.16
Growth Rate
Revenue Growth
17.64 %
Net Income Growth
8.92 %
Cash Flow Change
-68.79 %
ROE
-2.97 %
ROCE
-12.51 %
EBITDA Margin (Avg.)
4.20 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2,269
2,291
2,286
2,300
2,310
2,232
2,360
2,266
2,479
2,127
3,165
3,206
3,197
2,870
2,875
3,547
3,658
3,429
3,271
3,555
3,672
3,462
3,663
3,645
3,551
3,971
6,106
3,590
3,821
3,989
3,993
4,199
4,890
5,089
4,313
4,403
5,526
6,110
5,182
5,181
6,371
6,622
6,147
6,892
7,569
7,908
Expenses
1,792
1,807
1,740
1,768
1,784
1,763
1,841
1,907
2,004
1,909
2,365
2,404
2,399
2,249
2,273
2,738
2,932
2,864
3,009
2,947
3,013
2,724
2,977
2,867
2,916
3,092
2,860
2,895
3,103
3,251
3,319
3,301
4,359
3,650
3,224
3,403
3,903
4,124
3,776
3,882
4,622
4,485
4,142
5,133
5,430
6,106
EBITDA
477
484
546
532
526
468
519
359
476
218
800
802
798
621
601
809
726
565
262
608
658
738
686
779
635
879
3,246
695
718
738
673
898
532
1,439
1,089
1,000
1,623
1,986
1,407
1,299
1,749
2,137
2,005
1,759
2,139
1,802
Operating Profit %
20 %
20 %
23 %
22 %
21 %
20 %
21 %
15 %
17 %
9 %
25 %
24 %
24 %
19 %
20 %
22 %
19 %
16 %
7 %
17 %
17 %
20 %
17 %
20 %
19 %
21 %
22 %
18 %
17 %
17 %
16 %
21 %
10 %
28 %
24 %
22 %
27 %
32 %
26 %
24 %
27 %
31 %
31 %
24 %
27 %
22 %
Depreciation
76
69
73
74
76
84
86
90
114
122
126
147
144
142
148
154
156
172
172
174
179
173
175
176
175
183
177
177
185
181
182
182
179
180
184
195
205
215
234
229
238
238
302
360
508
555
Interest
16
12
13
12
16
14
15
7
10
22
41
13
15
35
36
46
77
89
90
81
83
68
45
27
23
27
30
31
39
34
35
33
28
18
9
20
35
32
25
32
77
85
101
130
123
156
Profit Before Tax
426
519
545
537
498
441
435
324
412
154
712
722
724
570
535
672
606
394
122
457
522
588
524
617
526
777
3,135
598
558
673
648
781
484
1,328
1,006
947
1,550
1,900
1,271
1,184
1,672
1,921
1,687
1,353
1,660
1,307
Tax
69
51
60
97
-74
36
46
-6
20
9
200
168
125
102
107
150
124
69
28
86
108
102
89
89
-210
135
123
87
105
96
122
149
125
195
203
157
304
417
351
158
428
400
449
331
319
316
Net Profit
357
468
485
440
572
405
389
331
393
145
513
553
599
467
428
522
482
325
94
371
414
487
435
528
735
643
3,012
511
453
576
526
631
358
1,134
803
790
1,246
1,483
920
1,026
1,244
1,521
1,239
1,023
1,341
990
EPS in ₹
17.11
22.47
6.46
4.21
5.59
3.89
3.71
3.16
3.77
1.35
4.92
5.31
5.77
4.50
4.08
4.99
4.40
2.97
1.05
3.65
3.83
4.43
4.62
5.15
6.64
5.74
29.32
4.89
3.88
5.06
5.15
6.15
2.93
10.74
7.91
7.80
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
12.65
9.35
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
9,047
10,551
15,221
18,065
23,483
23,687
23,885
27,795
25,756
29,281
37,202
52,407
Fixed Assets
3,352
3,748
5,755
6,483
12,164
12,231
12,133
12,189
11,521
12,369
13,134
24,106
Current Assets
4,227
4,280
6,022
8,230
8,498
8,715
8,716
12,095
10,008
11,420
17,046
19,906
Capital Work in Progress
798
951
1,543
1,527
837
742
783
726
1,201
2,423
2,692
3,699
Investments
121
416
435
746
674
765
830
3,288
1,547
1,221
6,412
7,540
Other Assets
4,776
5,436
7,488
9,310
9,809
9,950
10,139
11,593
11,488
13,269
14,964
17,062
Total Equity & Liabilities
9,047
10,551
15,221
18,065
23,483
23,687
23,885
27,795
25,756
29,281
37,202
52,407
Current Liabilities
3,285
3,461
5,306
6,083
7,343
8,269
7,861
7,827
5,527
5,340
9,042
15,712
Non Current Liabilities
1,342
1,255
2,799
3,047
4,461
3,707
1,094
915
541
1,840
1,802
7,113
Total Equity
4,421
5,835
7,116
8,936
11,679
11,710
14,930
19,054
19,688
22,102
26,358
29,582
Reserve & Surplus
4,149
5,597
6,858
8,642
10,284
10,273
12,890
16,897
17,415
19,729
23,853
27,011
Share Capital
102
102
102
102
102
102
102
102
101
101
101
101
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
178
99
756
-3
-811
399
-91
2,373
-534
-75
414
28
Investing Activities
-465
-860
-2,872
-974
-3,977
-1,012
-835
1,137
1,178
-1,492
-8,363
-7,895
Operating Activities
994
1,894
1,312
919
1,282
2,505
3,293
2,104
2,689
3,228
6,781
2,117
Financing Activities
-351
-935
2,316
52
1,885
-1,094
-2,549
-868
-4,400
-1,810
1,995
5,807
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.88 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.98 %
74.99 %
74.99 %
74.99 %
75.00 %
75.00 %
75.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.72 %
5.59 %
7.52 %
7.53 %
7.32 %
7.13 %
7.34 %
7.06 %
6.95 %
6.88 %
DIIs
11.11 %
10.43 %
11.22 %
11.78 %
12.78 %
11.92 %
12.94 %
13.69 %
13.60 %
13.23 %
13.09 %
12.79 %
12.63 %
12.64 %
10.65 %
10.65 %
11.01 %
11.13 %
10.86 %
11.09 %
11.20 %
11.27 %
Government
0.19 %
0.07 %
0.07 %
0.07 %
0.08 %
0.08 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.16 %
7.31 %
7.38 %
7.40 %
7.81 %
8.02 %
7.60 %
7.04 %
6.42 %
5.97 %
5.67 %
5.60 %
5.29 %
5.37 %
5.48 %
5.47 %
5.41 %
5.46 %
5.49 %
5.54 %
5.54 %
5.45 %
Others
7.66 %
7.32 %
6.44 %
5.87 %
4.46 %
5.11 %
4.48 %
4.29 %
5.00 %
5.82 %
6.26 %
6.63 %
1.38 %
1.43 %
1.37 %
1.36 %
1.28 %
1.28 %
1.32 %
1.31 %
1.32 %
1.38 %
No of Share Holders
0
2,23,384
3,31,155
3,51,595
3,70,931
4,08,017
4,55,624
4,08,231
3,70,396
3,11,764
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266
4,18,314
4,03,889

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 3.2 3.5 3.5 3.5 3.5 2.5 6 3 11 1
Dividend Yield (%) 0.85 1.01 1.31 0.79 1 0.51 0.6 0.34 1.26 0.09

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Jul 2021 DIVIDEND Dividend
₹ 3.50 /share
 28 Jul 2021 628.10 571.90
29 Jul 2022 DIVIDEND Dividend
₹ 2.50 /share
 28 Jul 2022 338.75 349.60
28 Jul 2023 DIVIDEND Dividend
₹ 6.00 /share
 28 Jul 2023 518.80 649.50
29 Feb 2024 BUYBACK Buyback
1005
 23 Feb 2024 953.75 932.80
26 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
 26 Jul 2024 1,009.00 1,205.80
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 09 Aug 2024 1,009.00 1,279.40
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2024 1,002.20 968.55
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Feb 2025 995.50 974.00
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2025 873.70 911.40
25 Jul 2025 DIVIDEND Dividend
₹ 11.00 /share
 25 Jul 2025 902.70 971.05
12 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 12 Aug 2025 911.40 955.50
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 969.80 955.50
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2025 1,001.35 971.70
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 09 Feb 2026 881.95 887.85
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2026 940.10 991.10
04 Jun 2026 BUYBACK Buyback
1260
 29 May 2026 1,105.75 1,076.45
24 Jul 2026 DIVIDEND Dividend
₹ 1.00 /share
 24 Jul 2026 991.10 1,113.80
11 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Aug 2026 991.10 1,119.00
11 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Aug 2026 1,143.70 1,119.00

Announcements

ESG Rating15 hrs ago
Disclosure Under SEBI (Prohibition Of Insider Trading) Regulations 20151 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation2 days ago
ESG Rating4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 11, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 11, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2026
Reporting Of Violation Of Code Of Conduct Under SEBI (Prohibition Of Insider Trading) Regulations 2015Aug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2026
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended On June 30 2026Aug 11, 2026
Unaudited Financial Results For The Quarter Ended On June 30 2026Aug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2026
Receipt Of Order From The Office Of The Superintendent Of Stamps Gandhinagar GujaratJul 29, 2026
Announcement under Regulation 30 (LODR)-Strikes /Lockouts / DisturbancesJul 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30 2026.Jul 20, 2026
Reply To The Clarification Sought From The CompanyJul 15, 2026
Clarification sought from Zydus Lifesciences LtdJul 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 10, 2026
Reg. 34 (1) Annual Report.Jul 10, 2026
Notice Of Annual General MeetingJul 10, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 03, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJun 29, 2026
Announcement under Regulation 30 (LODR)-Joint VentureJun 26, 2026
Closure of Trading WindowJun 25, 2026
Disclosures Under SEBI (Prohibition Of Insider Trading) Regulations 2015Jun 20, 2026
Corporate Action-Updates on Buy backJun 19, 2026
Corporate Action-Updates on Buy backJun 18, 2026
Completion Of Merger Of Assertio Holdings Inc.Jun 16, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 16, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Innovation Fund Direct-Growth
0.61%
90000
0.33%
0.61%
Samco Large Cap Fund Direct-Growth
2.98%
25948
2.98%
2.98%
Capitalmind Flexi Cap Fund Direct-Growth
2.73%
11367
0.27%
2.73%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
2.47%
-11000
-0.04%
0.49%
Samco Large & Mid Cap Fund Direct-Growth
0.99%
8854
0.99%
0.99%
The Wealth Company Large & Mid Cap Fund Direct-Growth
1.67%
8000
0.83%
1.67%
Capitalmind Multi Asset Allocation Fund Direct-Growth
2.70%
2070
0.55%
0.54%
JioBlackRock Nifty Next 50 Index Fund Direct-Growth
1.11%
724
-0.03%
0.04%
Parag Parikh Large Cap Fund Direct-Growth
0.20%
593
0.00%
0.00%
Nippon India Nifty 500 Low Volatility 50 Index Fund Direct-Growth
0.82%
-329
-0.13%
-0.11%
JioBlackRock Sector Rotation Fund Direct-Growth
0.22%
-261
-0.02%
0.02%
Tata Nifty Next 50 Index Fund Direct-Growth
1.11%
-192
-0.03%
0.04%
DSP Nifty Healthcare Index Fund Direct-Growth
2.45%
140
-0.11%
-0.14%
Kotak Nifty Alpha Low-Volatility 30 Index Fund Direct-Growth
2.46%
116
-0.09%
2.46%
Zerodha Life Cycle Fund 2041 Direct-Growth
0.08%
98
0.08%
0.08%
Zerodha Life Cycle Fund 2036 Direct-Growth
0.06%
80
0.06%
0.06%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth
0.66%
56
-0.01%
-0.02%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.07%
-41
0.00%
0.02%
Choice Nifty Next 50 Index Fund Direct-Growth
1.11%
39
-0.02%
0.04%
Groww Nifty Next 50 Index Fund Direct-Growth
1.11%
34
-0.02%
0.04%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.48%
-34
-0.02%
0.01%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth
0.07%
24
0.00%
0.00%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.13%
-14
-0.01%
-0.01%
Bajaj Finserv Nifty Next 50 Index Fund Direct-Growth
1.11%
6
-0.03%
0.03%
DSP Nifty 500 Index Fund Direct-Growth
0.14%
1
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
49.80
ATR(14)
Volatile
28.45
STOCH(9,6)
Oversold
14.53
STOCH RSI(14)
Oversold
13.04
MACD(12,26)
Bearish
-3.97
ADX(14)
Weak Trend
15.69
UO(9)
Bearish
43.29
ROC(12)
Uptrend And Accelerating
0.92
WillR(14)
Neutral
-71.62
Bearish
3
Neutral
3
Bullish
3

About Zydus Life Science

Zydus Lifesciences Limited is an Indian global life sciences company that discovers, develops, manufactures, and markets healthcare therapies. Its product portfolio includes active pharmaceutical ingredients, human formulations, animal health products, and wellness products. The company operates in pharmaceuticals, covering human and veterinary formulations, bulk drugs, diagnostics, herbal products, skin care,...more
Listing Date
27 Apr, 2000(26 Years, 3 Months, 30 Days)
Website
https://www.zyduscadila.com
Chairperson NamePankaj R Patel
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104